
Group Structure
View All
Industry
Other human health activities
Registered Address
3- 4 devonshire street, london, W1W 5DT
Pomanda estimates the enterprise value of AXIOM NEUROMONITORING LTD at £553.5k based on a Turnover of £1.1m and 0.51x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of AXIOM NEUROMONITORING LTD at £371.9k based on an EBITDA of £94k and a 3.95x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of AXIOM NEUROMONITORING LTD at £2m based on Net Assets of £862.6k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Axiom Neuromonitoring Ltd is a live company located in london, W1W 5DT with a Companies House number of 09160482. It operates in the other human health activities sector, SIC Code 86900. Founded in August 2014, it's largest shareholder is dale adam darbyshire with a 100% stake. Axiom Neuromonitoring Ltd is a established, small sized company, Pomanda has estimated its turnover at £1.1m with healthy growth in recent years.
Pomanda's financial health check has awarded Axiom Neuromonitoring Ltd a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
3 Weak
Size
annual sales of £1.1m, make it larger than the average company (£643k)
- Axiom Neuromonitoring Ltd
£643k - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a faster rate (5.8%)
- Axiom Neuromonitoring Ltd
5.8% - Industry AVG
Production
with a gross margin of 39.3%, this company has a comparable cost of product (39.3%)
- Axiom Neuromonitoring Ltd
39.3% - Industry AVG
Profitability
an operating margin of 6.8% make it as profitable than the average company (5.7%)
- Axiom Neuromonitoring Ltd
5.7% - Industry AVG
Employees
with 9 employees, this is below the industry average (17)
9 - Axiom Neuromonitoring Ltd
17 - Industry AVG
Pay Structure
on an average salary of £25.9k, the company has an equivalent pay structure (£25.9k)
- Axiom Neuromonitoring Ltd
£25.9k - Industry AVG
Efficiency
resulting in sales per employee of £119.9k, this is more efficient (£48.1k)
- Axiom Neuromonitoring Ltd
£48.1k - Industry AVG
Debtor Days
it gets paid by customers after 47 days, this is later than average (23 days)
- Axiom Neuromonitoring Ltd
23 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Axiom Neuromonitoring Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Axiom Neuromonitoring Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 66 weeks, this is less cash available to meet short term requirements (113 weeks)
66 weeks - Axiom Neuromonitoring Ltd
113 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.6%, this is a lower level of debt than the average (26.6%)
19.6% - Axiom Neuromonitoring Ltd
26.6% - Industry AVG
Axiom Neuromonitoring Ltd's latest turnover from August 2023 is estimated at £1.1 million and the company has net assets of £862.6 thousand. According to their latest financial statements, Axiom Neuromonitoring Ltd has 9 employees and maintains cash reserves of £247 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||
Other Income Or Grants | |||||||||
Cost Of Sales | |||||||||
Gross Profit | |||||||||
Admin Expenses | |||||||||
Operating Profit | |||||||||
Interest Payable | |||||||||
Interest Receivable | |||||||||
Pre-Tax Profit | |||||||||
Tax | |||||||||
Profit After Tax | |||||||||
Dividends Paid | |||||||||
Retained Profit | |||||||||
Employee Costs | |||||||||
Number Of Employees | 9 | 7 | 4 | 3 | 3 | 1 | 1 | ||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | |
---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 54,765 | 44,080 | 24,812 | 26,890 | 16,380 | 26,000 | 36,400 | 20,800 | |
Intangible Assets | |||||||||
Investments & Other | 73,250 | 73,250 | |||||||
Debtors (Due After 1 year) | |||||||||
Total Fixed Assets | 128,015 | 117,330 | 24,812 | 26,890 | 16,380 | 26,000 | 36,400 | 20,800 | |
Stock & work in progress | |||||||||
Trade Debtors | 141,444 | 200,807 | 112,350 | 112,540 | 264,914 | 213,156 | 86,744 | 105,623 | 24,740 |
Group Debtors | |||||||||
Misc Debtors | 556,417 | 473,512 | 350,415 | 281,725 | 5,990 | 4,866 | 285 | ||
Cash | 247,030 | 263,867 | 356,012 | 270,492 | 166,772 | 107,787 | 195,980 | 10,519 | 25,474 |
misc current assets | |||||||||
total current assets | 944,891 | 938,186 | 818,777 | 664,757 | 431,686 | 320,943 | 288,714 | 121,008 | 50,499 |
total assets | 1,072,906 | 1,055,516 | 843,589 | 691,647 | 448,066 | 346,943 | 325,114 | 141,808 | 50,499 |
Bank overdraft | 3,881 | ||||||||
Bank loan | 10,000 | 10,000 | 8,340 | ||||||
Trade Creditors | 119,834 | 158,855 | 19,497 | 5,849 | 22,125 | ||||
Group/Directors Accounts | 285 | ||||||||
other short term finances | |||||||||
hp & lease commitments | |||||||||
other current liabilities | 182,761 | 217,896 | 174,373 | 181,310 | 96,343 | 48,816 | |||
total current liabilities | 192,761 | 227,896 | 182,713 | 181,310 | 119,834 | 158,855 | 115,840 | 54,665 | 26,291 |
loans | 17,500 | 27,500 | 39,575 | ||||||
hp & lease commitments | |||||||||
Accruals and Deferred Income | |||||||||
other liabilities | 50,000 | ||||||||
provisions | |||||||||
total long term liabilities | 17,500 | 27,500 | 39,575 | 50,000 | |||||
total liabilities | 210,261 | 255,396 | 222,288 | 231,310 | 119,834 | 158,855 | 115,840 | 54,665 | 26,291 |
net assets | 862,645 | 800,120 | 621,301 | 460,337 | 328,232 | 188,088 | 209,274 | 87,143 | 24,208 |
total shareholders funds | 862,645 | 800,120 | 621,301 | 460,337 | 328,232 | 188,088 | 209,274 | 87,143 | 24,208 |
Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | |
---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||
Operating Profit | |||||||||
Depreciation | 20,420 | 14,560 | 12,840 | 15,888 | 10,660 | 10,400 | 10,400 | 5,200 | |
Amortisation | |||||||||
Tax | |||||||||
Stock | |||||||||
Debtors | 23,542 | 211,554 | 68,500 | 129,351 | 51,758 | 120,422 | -17,755 | 85,464 | 25,025 |
Creditors | -119,834 | -39,021 | 139,358 | 13,648 | -16,276 | 22,125 | |||
Accruals and Deferred Income | -35,135 | 43,523 | -6,937 | 181,310 | -96,343 | 47,527 | 48,816 | ||
Deferred Taxes & Provisions | |||||||||
Cash flow from operations | |||||||||
Investing Activities | |||||||||
capital expenditure | |||||||||
Change in Investments | 73,250 | ||||||||
cash flow from investments | |||||||||
Financing Activities | |||||||||
Bank loans | 1,660 | 8,340 | |||||||
Group/Directors Accounts | -285 | 285 | |||||||
Other Short Term Loans | |||||||||
Long term loans | -10,000 | -12,075 | 39,575 | ||||||
Hire Purchase and Lease Commitments | |||||||||
other long term liabilities | -50,000 | 50,000 | |||||||
share issue | |||||||||
interest | |||||||||
cash flow from financing | |||||||||
cash and cash equivalents | |||||||||
cash | -16,837 | -92,145 | 85,520 | 103,720 | 58,985 | -88,193 | 185,461 | -14,955 | 25,474 |
overdraft | -3,881 | 3,881 | |||||||
change in cash | -16,837 | -92,145 | 85,520 | 103,720 | 58,985 | -88,193 | 185,461 | -11,074 | 21,593 |
Perform a competitor analysis for axiom neuromonitoring ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in W1W area or any other competitors across 12 key performance metrics.
AXIOM NEUROMONITORING LTD group structure
Axiom Neuromonitoring Ltd has no subsidiary companies.
Ultimate parent company
AXIOM NEUROMONITORING LTD
09160482
Axiom Neuromonitoring Ltd currently has 1 director, Mr Dale Darbyshire serving since Aug 2014.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Dale Darbyshire | United Kingdom | 35 years | Aug 2014 | - | Director |
P&L
August 2023turnover
1.1m
-21%
operating profit
73.6k
0%
gross margin
39.4%
+3.9%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2023net assets
862.6k
+0.08%
total assets
1.1m
+0.02%
cash
247k
-0.06%
net assets
Total assets minus all liabilities
company number
09160482
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
August 2014
age
11
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
August 2023
previous names
spinal cord monitoring limited (November 2020)
accountant
MANSELL & CO
auditor
-
address
3- 4 devonshire street, london, W1W 5DT
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to axiom neuromonitoring ltd.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AXIOM NEUROMONITORING LTD. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|